Federated Hermes’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $111M | Sell |
797,709
-1,831,827
| -70% | -$257M | 0.18% | 127 |
|
|
2025
Q4 | $323M | Sell |
2,629,536
-26,296
| -1% | -$3.2M | 0.54% | 32 |
|
|
2025
Q3 | $295M | Sell |
2,655,832
-324,814
| -11% | -$36.9M | 0.52% | 38 |
|
|
2025
Q2 | $330M | Sell |
2,980,646
-1,885,664
| -39% | -$201M | 0.62% | 31 |
|
|
2025
Q1 | $545M | Sell |
4,866,310
-1,575,291
| -24% | -$163M | 1.18% | 9 |
|
|
2024
Q4 | $595M | Sell |
6,441,601
-688,145
| -10% | -$62M | 1.3% | 6 |
|
|
2024
Q3 | $598M | Buy |
7,129,746
+808,579
| +13% | +$61.7M | 1.31% | 6 |
|
|
2024
Q2 | $434M | Buy |
6,321,167
+1,036,932
| +20% | +$69.2M | 1.03% | 10 |
|
|
2024
Q1 | $387M | Buy |
5,284,235
+1,496,880
| +40% | +$115M | 0.89% | 16 |
|
|
2023
Q4 | $307M | Buy |
3,787,355
+175,925
| +5% | +$13.7M | 0.76% | 23 |
|
|
2023
Q3 | $271M | Buy |
3,611,430
+20,799
| +0.6% | +$1.6M | 0.72% | 25 |
|
|
2023
Q2 | $277M | Sell |
3,590,631
-2,050,261
| -36% | -$164M | 0.69% | 26 |
|
|
2023
Q1 | $468M | Sell |
5,640,892
-1,716,591
| -23% | -$142M | 1.18% | 10 |
|
|
2022
Q4 | $632M | Sell |
7,357,483
-779,455
| -10% | -$61.7M | 1.75% | 2 |
|
|
2022
Q3 | $502M | Buy |
8,136,938
+161,902
| +2% | +$10.2M | 1.47% | 4 |
|
|
2022
Q2 | $493M | Buy |
7,975,036
+1,008,339
| +14% | +$62.4M | 1.34% | 5 |
|
|
2022
Q1 | $414M | Buy |
6,966,697
+588,734
| +9% | +$37.6M | 0.94% | 11 |
|
|
2021
Q4 | $463M | Buy |
6,377,963
+119,615
| +2% | +$8.24M | 0.86% | 12 |
|
|
2021
Q3 | $437M | Buy |
6,258,348
+127,562
| +2% | +$8.96M | 0.83% | 14 |
|
|
2021
Q2 | $422M | Buy |
6,130,786
+24,756
| +0.4% | +$1.65M | 0.79% | 15 |
|
|
2021
Q1 | $395M | Buy |
6,106,030
+87,287
| +1% | +$5.63M | 0.77% | 18 |
|
|
2020
Q4 | $351M | Buy |
6,018,743
+876,362
| +17% | +$52.9M | 0.72% | 19 |
|
|
2020
Q3 | $325M | Buy |
5,142,381
+2,936,687
| +133% | +$204M | 0.76% | 19 |
|
|
2020
Q2 | $170M | Sell |
2,205,694
-4,930,612
| -69% | -$378M | 0.42% | 44 |
|
|
2020
Q1 | $534M | Buy |
7,136,306
+1,526,835
| +27% | +$106M | 1.57% | 8 |
|
|
2019
Q4 | $365M | Buy |
5,609,471
+31,684
| +0.6% | +$2.06M | 0.81% | 16 |
|
|
2019
Q3 | $354M | Buy |
5,577,787
+5,317,848
| +2,046% | +$348M | 0.87% | 20 |
|
|
2019
Q2 | $17.6M | Sell |
259,939
-7,263
| -3% | -$478K | 0.04% | 384 |
|
|
2019
Q1 | $17.4M | Sell |
267,202
-20,953
| -7% | -$1.39M | 0.04% | 378 |
|
|
2018
Q4 | $18M | Buy |
288,155
+56,053
| +24% | +$3.92M | 0.05% | 333 |
|
|
2018
Q3 | $17.9M | Buy |
232,102
+201,089
| +648% | +$15.2M | 0.04% | 382 |
|
|
2018
Q2 | $2.2M | Sell |
31,013
-2,892
| -9% | -$204K | 0.01% | 974 |
|
|
2018
Q1 | $2.56M | Sell |
33,905
-267,391
| -89% | -$21.3M | 0.01% | 865 |
|
|
2017
Q4 | $21.6M | Buy |
301,296
+93,682
| +45% | +$7.11M | 0.06% | 238 |
|
|
2017
Q3 | $16.8M | Buy |
207,614
+47,246
| +29% | +$3.61M | 0.05% | 288 |
|
|
2017
Q2 | $11.4M | Sell |
160,368
-159,261
| -50% | -$10.6M | 0.03% | 373 |
|
|
2017
Q1 | $21.7M | Sell |
319,629
-177,029
| -36% | -$12.4M | 0.06% | 274 |
|
|
2016
Q4 | $35.6M | Sell |
496,658
-231,884
| -32% | -$17.2M | 0.11% | 160 |
|
|
2016
Q3 | $57.6M | Sell |
728,542
-271,266
| -27% | -$22M | 0.17% | 111 |
|
|
2016
Q2 | $83.4M | Sell |
999,808
-388,885
| -28% | -$34.5M | 0.24% | 75 |
|
|
2016
Q1 | $128M | Sell |
1,388,693
-393,069
| -22% | -$35.4M | 0.4% | 48 |
|
|
2015
Q4 | $180M | Buy |
1,781,762
+38,512
| +2% | +$4.01M | 0.57% | 33 |
|
|
2015
Q3 | $171M | Buy |
1,743,250
+8,741
| +0.5% | +$971K | 0.55% | 33 |
|
|
2015
Q2 | $203M | Buy |
1,734,509
+130,532
| +8% | +$14.3M | 0.61% | 31 |
|
|
2015
Q1 | $157M | Sell |
1,603,977
-22,379
| -1% | -$2.27M | 0.48% | 42 |
|
|
2014
Q4 | $153M | Buy |
1,626,356
+236,349
| +17% | +$24.4M | 0.47% | 41 |
|
|
2014
Q3 | $148M | Sell |
1,390,007
-83,725
| -6% | -$8.2M | 0.48% | 41 |
|
|
2014
Q2 | $122M | Buy |
1,473,732
+22,973
| +2% | +$1.79M | 0.38% | 49 |
|
|
2014
Q1 | $103M | Sell |
1,450,759
-307,442
| -17% | -$24.1M | 0.34% | 59 |
|
|
2013
Q4 | $132M | Sell |
1,758,201
-183,016
| -9% | -$12.7M | 0.46% | 44 |
|
|
2013
Q3 | $122M | Sell |
1,941,217
-1,165,050
| -38% | -$69.6M | 0.47% | 43 |
|
|
2013
Q2 | $159M | Buy |
+3,106,267
| New | +$162M | 0.63% | 32 |
|
Other funds holding GILD
VCM
VPM
Federated Hermes's GILD Position: Q1 2026 in Review
Federated Hermes reduced its Gilead Sciences (GILD) stake by 70% in Q1 2026, selling an estimated $257M and leaving 797,709 shares worth $111M. The position accounts for 0.18% of the portfolio, ranked #127.
Federated Hermes first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $632M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Federated Hermes held 797,709 shares of Gilead Sciences worth $111M as of Q1 2026.
- Federated Hermes sold 1,831,827 Gilead Sciences shares in Q1 2026, an estimated $257M.
- Gilead Sciences made up 0.18% of Federated Hermes's portfolio in Q1 2026, its #127 holding.
- Federated Hermes first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Federated Hermes's Gilead Sciences position peaked at $632M in Q4 2022.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.